Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10016


Purpose:

This study will evaluate the lung's immune response to mycobacterium tuberculosis (Mtb) infection and will modulate that response with interferon-gamma.


Study summary:

BACKGROUND: Mtb infects one-third of the world's population and ranks seventh in terms of global morbidity and mortality. Patients with bilateral pulmonary tuberculosis (TB), cavitary disease, and persistently positive sputum smears pose a special risk for treatment failure and/or relapse. DESIGN NARRATIVE: Cavitary pulmonary TB will be studied and interferon-gamma will be used as the intervention. The outcome of this study will be the changes in mycobacteriology, chest radiography, and bronchoalveolar lavage (BAL) cells. The primary outcome will be sputum conversion, which will be measured at Weeks 4 and 8. The key secondary outcomes of this study will include a chest computerized tomography (CT) scan and BAL to measure the flow of cytometry and cytokine levels. Both outcomes will be measured at baseline and at Month 4.


Criteria:

Inclusion Criteria: - Positive acid-fast bacillus (AFB) smear within 14 days prior to randomization - Cluster of Differentiation 4 greater than 200 if HIV positive - Ability to sign consent - Bilateral, cavitary pulmonary TB Exclusion Criteria: - Multidrug-resistant (MDR) TB - Extrapulmonary TB - HIV positive with opportunistic infection within 30 days of study entry - Cancer - Asthma - Pregnant or lactating women - Chronic heart disease - Chronic liver disease - Chronic renal disease - Seizure disorder - Bleeding or clotting disorder - Diabetes mellitus


NCT ID:

NCT00201123


Primary Contact:

Principal Investigator
William Rom, MD, MPH
NYU School of Medicine


Backup Contact:

N/A


Location Contact:

New York, New York 10016
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.